Literature DB >> 17583558

Sample size estimation for non-inferiority trials of time-to-event data.

Adam Crisp1, Paula Curtis.   

Abstract

We consider the problem of sample size calculation for non-inferiority based on the hazard ratio in time-to-event trials where overall study duration is fixed and subject enrollment is staggered with variable follow-up. An adaptation of previously developed formulae for the superiority framework is presented that specifically allows for effect reversal under the non-inferiority setting, and its consequent effect on variance. Empirical performance is assessed through a small simulation study, and an example based on an ongoing trial is presented. The formulae are straightforward to program and may prove a useful tool in planning trials of this type. (c) 2007 John Wiley & Sons, Ltd.

Mesh:

Year:  2008        PMID: 17583558     DOI: 10.1002/pst.292

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  4 in total

1.  Sample size calculations for noninferiority trials for time-to-event data using the concept of proportional time.

Authors:  Milind A Phadnis; Matthew S Mayo
Journal:  J Appl Stat       Date:  2020-04-24       Impact factor: 1.416

2.  Design of non-inferiority randomized trials using the difference in restricted mean survival times.

Authors:  Isabelle R Weir; Ludovic Trinquart
Journal:  Clin Trials       Date:  2018-08-03       Impact factor: 2.486

3.  Power and sample size for randomized phase III survival trials under the Weibull model.

Authors:  Jianrong Wu
Journal:  J Biopharm Stat       Date:  2015       Impact factor: 1.051

4.  Choice of non-inferiority (NI) margins does not protect against degradation of treatment effects on an average--an observational study of registered and published NI trials.

Authors:  Beryl Primrose Gladstone; Werner Vach
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.